The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Maarten Jan Suttorp

Showing 1-17 of 17 articles
Coronary interventions
Optical coherence tomography findings: insights from the “randomised multicentre trial investigating angiographic outcomes of hybrid sirolimus-eluting stents with biodegradable polymer compared with everolimus-eluting stents with durable polymer in chronic total occlusions” (PRISON IV) trial
Teeuwen K, Spoormans E, Bennett J, Dubois C, Desmet W, Ughi G, Belmans A, Kelder J, Tijssen J, Agostoni P, Suttorp MJ, Adrianssens T
August 4, 2017 | 10.4244/EIJ-D-17-00261
Coronary interventions
Evaluation of a crystalline sirolimus-eluting coronary stent with a bioabsorbable polymer designed for rapid dissolution: two-year outcomes from the DESSOLVE I and II trials
Wijns W, Suttorp MJ, Zagozdzon L, Morice M, McClean D, Stella P, Donohoe D, Knape C, Ormiston J
June 20, 2016 | 10.4244/EIJY15M09_14
Initial experience with therapeutic geometric modification of the carotid bulb for true resistant hypertension
Habib N, Mahmoodi BK, Bos WJ, Tromp SC, Suttorp MJ, Bates MC, Van der Heyden J
May 19, 2015 | 10.4244/EIJV11I1A20
Three-year clinical outcome in the Primary Stenting of Totally Occluded Native Coronary Arteries III (PRISON III) trial: a randomised comparison between sirolimus-eluting stent implantation and zotarolimus-eluting stent implantation for the treatment of total coronary occlusions
Teeuwen K, Van den Branden B, Koolen J, van der Schaaf R, Henriques J, Thijssen J, Kelder J, Vermeersch P, Rensing B, Suttorp MJ
March 20, 2015 | 10.4244/EIJY14M08_07
Percutaneous reclosure of a patent foramen ovale after bioabsorbable device implantation
Snijder R, Post M, Suttorp MJ
November 20, 2014 | 10.4244/EIJV10I7A146
Primary Stenting of Totally Occluded Native Coronary Arteries III (PRISON III): a randomised comparison of sirolimus-eluting stent implantation with zotarolimus-eluting stent implantation for the treatment of total coronary occlusions
Van den Branden B, Teeuwen K, Koolen J, van der Schaaf R, Henriques J, Thijssen J, Kelder J, Vermeersch P, Rensing B, Suttorp MJ
November 29, 2013 | 10.4244/EIJV9I7A138
Late catch-up in lumen diameter at five-year angiography in MACE-free patients treated with sirolimus-eluting stents in the Primary Stenting of Totally Occluded Native Coronary Arteries: a randomised comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions (PRISON II)
Teeuwen K, Van den Branden B, Rahel B, Laarman G, Thijssen J, Kelder J, Slagboom T, ten Berg J, Suttorp MJ
June 28, 2013 | 10.4244/EIJV9I2A36
Five-year clinical outcome after primary stenting of totally occluded native coronary arteries: a randomised comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions (PRISON II study)
Van den Branden B, Rahel B, Laarman G, Slagboom T, Kelder J, ten Berg J, Suttorp MJ
February 21, 2012 | 10.4244/EIJV7I10A190
Comparison of outcome after patent foramen ovale closure in older versus younger patients
Luermans J, Budts W, ten Berg J, Plokker H, Suttorp MJ, Post M
June 30, 2011 | 10.4244/EIJV7I2A35
CT measurement of changes in cerebral perfusion in patients with asymptomatic carotid artery stenosis undergoing carotid stenting prior to cardiac surgery: "proof of principle"
Van der Heyden J, Waaijer A, Van ES W, van Neerven D, Sonker U, Suttorp MJ, Bal E, Prokop M
April 20, 2011
Long-term follow-up of the randomised controlled trial to evaluate the safety and efficacy of the zotarolimus-eluting driver coronary stent in de novo native coronary artery lesions: five year outcomes in the ENDEAVOR II study
Fajadet J, Wijns W, Laarman GJ, Kuck K, Ormiston J, Baldus S, Hauptmann K-E, Suttorp MJ, Drzewiecki J, Pieper M, Schultheiss H-P, Mauri L
November 15, 2010
Long-term outcome of percutaneous closure of secundum-type atrial septal defects in adults
Luermans J, Post M, ten Berg J, Plokker H, Suttorp MJ
November 15, 2010
The BioSTAR® device versus the CardioSEAL® device in patent foramen ovale closure: comparison of mid-term efficacy and safety
Van den Branden B, Luermans J, Post M, Plokker H, ten Berg J, Suttorp MJ
September 30, 2010
Two year follow-up after primary PCI with a paclitaxel-eluting stent versus a bare-metal stent for acute ST-elevation myocardial infarction (the PASSION trial): a follow-up study
Dirksen M, Vink M, Suttorp MJ, Thijssen J, Patterson M, Slagboom T, Kiemeneij F, Laarman GJ
May 13, 2008
A novel ultra-thin bare metal stent (BMS): results from a worldwide registry
Blanchard D, Danzi G, Urban P, Moseri M, Juergens C, Guyon P, Nowak B, Tresukosol D, Suttorp MJ, Farshid A, Kornowski R, Garcia E, Yeend R, Nagai H, Paunovic D
August 20, 2007
Safety of direct stenting with the Endeavor stent: results of the Endeavor II continued access registry
Schultheiss H-P, Grube E, Kuck K, Suttorp MJ, Heuer H, Bonnier H, Popma J, Kuntz R, Fajadet J, Wijns W
May 22, 2007
One-year results of coronary revascularization in diabetic patients with multivessel coronary artery disease.
Macaya C, Garcia-Garcia H, Colombo A, Morice M, Legrand V, Kuck K, Sheiban I, Suttorp MJ, Carrié D, Vrolix M, Wittebols K, Stoll H, Donohoe D, Bressers M, Serruys P
May 20, 2006

Latest news

EDITORIAL
A State-of-the Art and Mini Focus on Intracoronary OCT; Thrombectomy for Acute Ischaemic Stroke; and more…
June 11, 2021
NEW
Intracoronary OCT: State of the Art and Future Directions
Ziad A. Ali et al.
June 11, 2021
PCR Companion attending EuroPCR? Activate your free subscription!
May 28, 2021
TRIALS BOOK
Access the full Trials Book 2021
(Thanks to the support of Biotronik)
May 18, 2021
JAA
This Week's JAA's: ABSORB DAPT, OFR in predicting post-PCI FFR and more...
June 8, 2021
NEW
Joint EAPCI/ACVC expert consensus on pVADs
Alaide Chieffo et al.
May 31, 2021
JAA
New JAA's: Impact of HPR on clopidogrel monotherapy and more...
May 25, 2021
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke